Deal supported by Xplico

By |September, 2013|

Roche and Inovio Pharmaceuticals partner on Inovio’s prostate cancer and hepatitis B immunotherapy products

Deal supported by Xplico

By |June, 2013|

Novavax Announces Public Offer for All Outstanding Shares of Isconova

Deal supported by Xplico

By |February, 2013|

4SC Discovery and LEO Pharma announce exclusive research and license agreement for inflammatory skin diseases